Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Paintaud

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
Therapie|May 26, 2009
[Acute lithium intoxications, review of the literature and cases study]Corinne Schmitt, Yves Furet, Dominique Perrotin, et al.
Mabs|March 2, 2011
Therapeutic antibodies in ophthalmology: old is new againCharlotte Magdelaine-Beuzelin, Coralie Pinault, Gilles Paintaud, et al.
Cancer Chemotherapy and Pharmacology|October 19, 2016
Gota et al. on their article "the pharmacokinetics of Reditux™, a biosimilar of rituximab"Mira Tout, Christophe Passot, Guillaume Cartron, et al.
Therapeutic Drug Monitoring|September 16, 2016
Cetuximab Pharmacokinetics Influences Overall Survival in Patients With Head and Neck CancerYoann Pointreau, Nicolas Azzopardi, David Ternant, et al.
British Journal of Clinical Pharmacology|December 3, 2020
Letter to Dreesen et al. on their article "Modelling of the Relationship Between Infliximab Exposure, Faecal Calprotectin, and Endoscopic Remission in Patients With Crohn's Disease"-A comprehensive review of infliximab population pharmacokinetic modelling publicationsOlivier Le Tilly, Theodora Bejan-Angoulvant, Gilles Paintaud, et al.
Therapie|May 26, 2009
[Monoclonals antibodies: a recent and major therapeutic advance]Gilles Paintaud, Fabien Lejarre, David Ternant, et al.
British Journal of Clinical Pharmacology|May 30, 2013
Influence of plasma exchange on rituximab pharmacokineticsNicolas Azzopardi, Maud François, Emeline Laurent, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2018
Pharmacokinetics partly explains the relationship between carcinoembryonic antigen level and survival of colorectal cancer patients treated with ramucirumabSajida Ibrahim, William Raoul, Thierry Lecomte, et al.
Journal of the American Academy of Dermatology|September 17, 2013
Systematic review of the efficacy and adverse events associated with infliximab treatment of hidradenitis suppurativa in patients with coexistent inflammatory diseasesLaurent Machet, Mahtab Samimi, Maïa Delage, et al.
Arthritis and Rheumatism|December 1, 2007
Can sciatica induced by disc herniation be treated with tumor necrosis factor alpha blockade?Philippe Goupille, Denis Mulleman, Gilles Paintaud, et al.
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
Therapie|May 26, 2009
[Acute lithium intoxications, review of the literature and cases study]Corinne Schmitt, Yves Furet, Dominique Perrotin, et al.
Mabs|March 2, 2011
Therapeutic antibodies in ophthalmology: old is new againCharlotte Magdelaine-Beuzelin, Coralie Pinault, Gilles Paintaud, et al.
Cancer Chemotherapy and Pharmacology|October 19, 2016
Gota et al. on their article "the pharmacokinetics of Reditux™, a biosimilar of rituximab"Mira Tout, Christophe Passot, Guillaume Cartron, et al.
Therapeutic Drug Monitoring|September 16, 2016
Cetuximab Pharmacokinetics Influences Overall Survival in Patients With Head and Neck CancerYoann Pointreau, Nicolas Azzopardi, David Ternant, et al.
British Journal of Clinical Pharmacology|December 3, 2020
Letter to Dreesen et al. on their article "Modelling of the Relationship Between Infliximab Exposure, Faecal Calprotectin, and Endoscopic Remission in Patients With Crohn's Disease"-A comprehensive review of infliximab population pharmacokinetic modelling publicationsOlivier Le Tilly, Theodora Bejan-Angoulvant, Gilles Paintaud, et al.
Therapie|May 26, 2009
[Monoclonals antibodies: a recent and major therapeutic advance]Gilles Paintaud, Fabien Lejarre, David Ternant, et al.
British Journal of Clinical Pharmacology|May 30, 2013
Influence of plasma exchange on rituximab pharmacokineticsNicolas Azzopardi, Maud François, Emeline Laurent, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2018
Pharmacokinetics partly explains the relationship between carcinoembryonic antigen level and survival of colorectal cancer patients treated with ramucirumabSajida Ibrahim, William Raoul, Thierry Lecomte, et al.
Journal of the American Academy of Dermatology|September 17, 2013
Systematic review of the efficacy and adverse events associated with infliximab treatment of hidradenitis suppurativa in patients with coexistent inflammatory diseasesLaurent Machet, Mahtab Samimi, Maïa Delage, et al.
Arthritis and Rheumatism|December 1, 2007
Can sciatica induced by disc herniation be treated with tumor necrosis factor alpha blockade?Philippe Goupille, Denis Mulleman, Gilles Paintaud, et al.
Pageof 16